Infineon Technologies Americas Corp. et al. v. MOSAID Technologies Inc.

IPR2025-01171

The Director denied institution of an IPR against MOSAID's patent, ruling that Infineon failed to adequately explain conflicting claim construction positions taken in district court litigation.

Jurisdiction
US PTAB
Case Number
IPR2025-01171
Filing Date
20 June 2025
Outcome
denied

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Infineon Technologies Americas Corp. et al. vs MOSAID Technologies Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-00827

Uber Technologies, Inc.vsEnovsys, LLC

The PTAB denied institution of an IPR challenging claims related to location tracking and wireless systems. The Board found insufficient evidence that the challenged claims would be obvious over the cited prior art, particularly regarding specific limitations like 'tracking period' or 'tracking request.'

patentIPR2025-01336

Meta Platforms, Inc.vsDialect, LLC

The USPTO denied institution for IPR2025-01336 after reviewing the merits. The petitioner failed to meet the standard of showing a reasonable likelihood of prevailing on at least one challenged claim.

patentIPR2024-00690

Dyson Technology Limited et al.vsOmachron Intellectual Property Inc. et al.

Dyson Technology Limited successfully petitioned to invalidate Omachron Intellectual Property's vacuum cleaner patent (US 10,117,550). The petition asserted grounds of anticipation and obviousness based on multiple prior art references.

patentIPR2024-00861

Abbott Diabetes Care Inc. et al.vsDexCom, Inc.

Abbott Diabetes Care Inc. filed an IPR petition challenging DexCom's remote monitoring patents, arguing that the claims are obvious. The petitioner asserts that various combinations of prior art references render the claimed methods and systems unpatentable.

patentPGR2025-00085

Alvotech USA Inc. et al.vsRegeneron Pharmaceuticals, Inc.

The PTAB granted institution for the PGR proceeding (PGR2025-00085) involving Alvotech and Regeneron regarding patent 12168036. The petitioner met the likelihood of prevailing standard.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call